FindTrial
Sign In

A multicenter randomized controlled trial for Chere Cunjin granules in the treatment of Sjogren's syndrome

A multicenter randomized controlled trial for Chere Cunjin granules in the treatment of Sjogren's syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020954
Enrollment
Unknown
Registered
2019-01-23
Start date
2019-01-12
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sjogren syndrome

Interventions

Test Group:Chere Cunjin Granules
Control Group:Shasheng Maidong Granules

Sponsors

Chongqing Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of Western medicine; 2. Meet the diagnostic criteria of TCM; 3. Aged 18 to 65 years; 4. Sign an informed consent.

Exclusion criteria

Exclusion criteria: 1. Secondary Sjogren's syndrome; 2. Primary Sjogren's syndrome affects extra-glandular organs, causing systemic systemic damage requiring additional drugs; 3. Other connective tissue diseases,lymphoma, AIDS,sarcoidosis,graft-versus-host disease,advanced lymphoid tissue hyperplasia; 4. Combined with severe primary diseases such as cardiovascular, liver, kidney and hematopoietic system; 5. Pregnancy, lactating women, allergies; 6. Psychiatric patients and other uncooperative.

Design outcomes

Primary

MeasureTime frame
ESSPRI score;ESSDAI score;Schirmer ? test;Salivary flow rate;Syndrome integral scale;—

Secondary

MeasureTime frame
erythrocyte sedimentation rate (ESR);C reactive protein(CRP);immunoglobulin;—

Countries

China

Contacts

Public ContactWang Shasha
frencence@163.com+86 15334520604

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026